Biotech Patents (Biotech Patents)

Venue: Warwick Hotel

Location: New York, New York, -

Event Date/Time: Sep 19, 2005 End Date/Time: Sep 20, 2005
Report as Spam


With millions in future revenue at stake, it is imperative that counsel to biotech and pharmaceutical companies and their advisors have an up-to-the-minute and complete understanding of the latest legal developments affecting biotech patents. This American Conference Institute conference will bring you thoughtful and targeted commentary and in-depth analysis from an outstanding faculty of leading in-house biotech and pharmaceutical counsel and expert attorneys. They will provide practical, comprehensive information and insights on:

* The industry debate for and against follow-on biologics
* How the CREATE Act and proposed patent reforms will shape the future of biotech patent practice
* The continuing impact of Festo
* Practical applications of the Doctrine of
Equivalents in biotechnology: protein therapeutics and beyond
* 35 USC ยง 112 Update: how key decisions on written description, enablement and utility will influence biotech patenting
* New and emerging trends in claim construction: an examination of Phillips
* Understanding the complexities of the Doctrines of Inherent and Accidental Anticipation and how they affect biotech inventions
* Tips for antibody claims and disclosure drafting in the US and EU
* When should you declare an interference?
* The repercussions of the Trilateral Report on 3D Crystal Structure on protein crystallography
* When should the opinion of outside counsel be sought in a freedom to operate analysis?
* International and domestic biotech licensing strategies: tips and traps


65 West 54th Street
New York
New York